In summary, our work determined that MARCH1 has an important role in the development and progression of hepatocellular carcinoma and may be used as a novel potential molecular therapeutic target in the future treatment of hepatocellular carcinoma. This evidence concerns the gene MARCHF1 and hepatocellular carcinoma.